Transmission of SARS-CoV-2 through breast milk and breastfeeding: a living systematic review

Elizabeth Centeno-Tablante1, Melisa Medina-Rivera1, Julia L Finkelstein1

  • 1Division of Nutritional Sciences, Cornell University, Ithaca, New York.

Insights

Current research indicates no evidence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission via breast milk. Further studies are needed to confirm infant feeding practices and viral presence in breast milk.

Area of Science:

  • Virology
  • Infectious Diseases
  • Public Health

Background:

  • The COVID-19 pandemic, caused by SARS-CoV-2, presents uncertainties regarding mother-to-child transmission.
  • Limited data exists on the potential for SARS-CoV-2 transmission through breast milk and breastfeeding.

Purpose of the Study:

  • To conduct a living systematic review to assess the risk of SARS-CoV-2 transmission via breast milk.
  • To inform updated guidance on breastfeeding practices during the COVID-19 pandemic.

Main Methods:

  • Systematic review of retrieved records.
  • Analysis of 37 articles with breast milk samples from mothers with COVID-19.
  • Inclusion of 340 records, with 37 analyzing breast milk samples.

Main Results:

  • Of 77 breastfeeding mothers with COVID-19, 19 children had confirmed COVID-19.
  • SARS-CoV-2 RNA was detected in 9 of 68 analyzed breast milk samples.
  • Infant SARS-CoV-2 status varied (4 positive, 2 negative) among those with analyzed breast milk samples.

Conclusions:

  • Current evidence does not support SARS-CoV-2 transmission through breast milk.
  • Further research with longer follow-up is required to evaluate infant feeding practices and viral presence in breast milk.

Related Concept Videos

Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

Transmission-based Precautions I: Contact, Enteric, and Droplets

Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
4.3K
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.7K
Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
3.9K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.8K